ReviewACS polymers Au2025
Synergistic Advances in Additive Manufacturing and Surface Engineering for Polymeric Biomedical Devices.
Review in ACS polymers Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Comprehensive Review on Thermoplastic Polyurethane: Applications in Wound Healing and Smart Healthcare.Biomimetics (Basel, Switzerland) · 2026Review
- PEEK in modern maxillofacial surgery: clinical applications, limitations and future opportunities.British dental journal · 2026Review
- 2D MoSNano convergence · 2026Article
- Additive Manufacturing in Organic Chemistry: From Synthesis to Sustainable Process Design.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Additive manufacturing (AM) of polymeric materials is rapidly transforming the biomedical field by enabling the fabrication of patient-specific, anatomically complex structures with precise control over internal architecture. Polymers are especially attractive for AM of biomedical devices due to their cost-effectiveness, abundance, low density, and tunable mechanical and degradation properties, supporting diverse applications in soft and hard tissue engineering, microfluidics, and drug delivery. However, many medical-grade polymers interact poorly with mammalian cells and tissues due to the lack of bioactive surface functional groups, which can hinder their performance in biomedical applications that rely on cell-material interactions such as tissue regeneration. This review systematically surveys physical, chemical, and biomimetic surface modification techniques for AM-compatible medical polymers to improve biomedical applications and targeted functionalities. While much attention has been paid in the literature to surface modification in bone tissue engineering, functional coatings incorporating bioactive molecules and nanoparticles further provide antibacterial, anti-inflammatory, and pro-regenerative functions. A major emphasis of this review is the synergy between AM and surface engineering, enabling simultaneous optimization of internal architecture and surface bioactivitycapabilities fundamentally unattainable by conventional manufacturing techniques. Finally, challenges such as sterilization compatibility and long-term stability of surface modifications are discussed as key to clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.